Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mackiewicz

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Oncogene|July 3, 1999
Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1M Kortylewski, P C Heinrich, A Mackiewicz, et al.
Oncogene|April 21, 2001
The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cellsS Ozbek, M Peters, K Breuhahn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsivenessM Wysocka, S Robertson, H Riemann, et al.
Cancer Letters|January 15, 1997
New protein and PCR markers RAK for diagnosis, prognosis and surgery guidance for breast cancerE M Rakowicz-Szulczynska, M Markowski, A Mackiewicz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1996
Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cellsH Baumann, Y Wang, K K Morella, et al.
Human Mutation|January 4, 2001
BRCA2 germline mutations in male breast cancer patients in the Polish populationE Kwiatkowska, M Teresiak, K M Lamperska, et al.
International Journal of Oncology|May 5, 2011
Diagnostic evaluation of cancer antigens RAK .1. Cervical and ovarian cancerE Rakowiczszulczynska, A Roszak, A Mackiewicz, et al.
European Journal of Immunology|February 1, 1993
The soluble interleukin-6 receptor is generated by sheddingJ Müllberg, H Schooltink, T Stoyan, et al.
Anticancer Research|March 26, 2002
Butyric acid enhances in vivo expression of hTNF-alpha in transduced melanoma cell lineA Giermasz, T Grzela, D Nowis, et al.
Leukemia|May 23, 2001
Potentiatied antitumor effectiveness of combined chemo-immunotherapy with interleukin-12 and 5-fluorouracil of L1210 leukemia in vivoJ Goł b, R Zagozdzon, R Kamiński, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Oncogene|July 3, 1999
Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1M Kortylewski, P C Heinrich, A Mackiewicz, et al.
Oncogene|April 21, 2001
The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cellsS Ozbek, M Peters, K Breuhahn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsivenessM Wysocka, S Robertson, H Riemann, et al.
Cancer Letters|January 15, 1997
New protein and PCR markers RAK for diagnosis, prognosis and surgery guidance for breast cancerE M Rakowicz-Szulczynska, M Markowski, A Mackiewicz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1996
Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cellsH Baumann, Y Wang, K K Morella, et al.
Human Mutation|January 4, 2001
BRCA2 germline mutations in male breast cancer patients in the Polish populationE Kwiatkowska, M Teresiak, K M Lamperska, et al.
International Journal of Oncology|May 5, 2011
Diagnostic evaluation of cancer antigens RAK .1. Cervical and ovarian cancerE Rakowiczszulczynska, A Roszak, A Mackiewicz, et al.
European Journal of Immunology|February 1, 1993
The soluble interleukin-6 receptor is generated by sheddingJ Müllberg, H Schooltink, T Stoyan, et al.
Anticancer Research|March 26, 2002
Butyric acid enhances in vivo expression of hTNF-alpha in transduced melanoma cell lineA Giermasz, T Grzela, D Nowis, et al.
Leukemia|May 23, 2001
Potentiatied antitumor effectiveness of combined chemo-immunotherapy with interleukin-12 and 5-fluorouracil of L1210 leukemia in vivoJ Goł b, R Zagozdzon, R Kamiński, et al.
Pageof 11